We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Confocal Microscopy of Benign and Malignant Skin Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01010321
Recruitment Status : Suspended
First Posted : November 10, 2009
Last Update Posted : June 29, 2010
Sponsor:
Information provided by:

Study Description
Brief Summary:
The investigators speculate that this tool may be used as an alternative and convenient non-invasive diagnostic of skin cancer.

Condition or disease Intervention/treatment
Skin Cancer Device: confocal microscopy

Study Design

Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Confocal Microscopy of Benign and Malignant Skin Tumors
Study Start Date : November 2009
Estimated Primary Completion Date : November 2010
Estimated Study Completion Date : November 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Skin Cancer
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
all study Population
all
Device: confocal microscopy
non-invasive imaging


Outcome Measures

Primary Outcome Measures :
  1. efficacy of a confocal microscope as a diagnostic tool [ Time Frame: 1 year ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Men and women over the age of 18

- Skin lesion suspected to either BCC,SCC etc

Criteria

Inclusion Criteria:

  • Men and women over the age of 18
  • Skin lesion suspected to either BCC or SCC etc
  • Patient was referred for biopsy diagnostic/therapeutic before hand, and regardless of confocal microscope examination, according to the clinical consideration of physician

Exclusion Criteria:

  • Pregnant women
  • Children
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01010321


Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Aviv Barzilai, Dr. Sheba Medical Center
More Information

Responsible Party: Dr. Aviv Barzilai, Sheba Medical Cener, Dermatology Unit
ClinicalTrials.gov Identifier: NCT01010321     History of Changes
Other Study ID Numbers: SHEBA-09-7295-AB-CTIL
First Posted: November 10, 2009    Key Record Dates
Last Update Posted: June 29, 2010
Last Verified: June 2010

Keywords provided by Sheba Medical Center:
skin lesion suspect as BCC or SCC or others

Additional relevant MeSH terms:
Skin Neoplasms
Neoplasms by Site
Neoplasms
Skin Diseases